Mr. Filipczak is a Managing Director and has been with Destum Partners since the company’s inception. Tom is exclusively focused in the biopharma sector, and is responsible for selecting and executing upon advisory and consulting mandates.
Experience
Mr. Filipczak has 16 years commercial experience in the pharmaceutical and biotech arena in various therapeutic areas with emphasis in transplantation, immunology, infectious disease, and oncology. His background includes account management and new business development with expertise in product launches. Before joining Destum Partners, Mr. Filipczak worked as Regional Sales Manager for Vicuron Pharmaceuticals. At Vicuron, he deployed a sales team for the launch of two proprietary compounds, ERAXIS™ (anidulafungin) and Zeven™ (dalbavancin), before being acquired by Pfizer. Prior to working at Vicuron, Mr. Filipczak was a Regional Sales Manager at Roche Pharmaceuticals where he successfully launched the transplantation and infectious disease portfolio including CellCept®, Zenapax®, Cytovene®, Valcyte®, and Pegasys®. He developed several strategies and tactics to ensure growth of the franchise to the peak level at Roche. His pharmaceutical career began with Sandoz (Novartis) Pharmaceuticals with positions of increased responsibility in primary care, specialty care, and the hospital market places.
Education
Mr. Filipczak holds a Bachelors Degree in Business Administration with majors in Finance and Management from Indiana University School of Business.